William Blair Weighs in on Danaher’s Q2 Earnings (NYSE:DHR)

Danaher Co. (NYSE:DHR) – Analysts at William Blair dropped their Q2 2025 EPS estimates for shares of Danaher in a report released on Thursday, January 30th. William Blair analyst M. Larew now expects that the conglomerate will post earnings of $1.82 per share for the quarter, down from their prior estimate of $1.92. The consensus estimate for Danaher’s current full-year earnings is $8.15 per share. William Blair also issued estimates for Danaher’s Q4 2025 earnings at $2.24 EPS, Q2 2026 earnings at $2.04 EPS, Q3 2026 earnings at $2.15 EPS, Q4 2026 earnings at $2.48 EPS and FY2026 earnings at $8.49 EPS.

Several other brokerages have also recently commented on DHR. Stifel Nicolaus raised their target price on shares of Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a report on Wednesday, October 23rd. Bank of America upgraded Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price objective for the company in a research report on Friday, December 13th. StockNews.com downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, December 14th. Scotiabank started coverage on Danaher in a research note on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 target price on the stock. Finally, Robert W. Baird cut their target price on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a research report on Tuesday. Six research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Danaher currently has an average rating of “Moderate Buy” and a consensus target price of $278.00.

Danaher Trading Down 0.2 %

Shares of NYSE DHR opened at $222.56 on Friday. The business has a fifty day simple moving average of $235.66 and a 200-day simple moving average of $253.24. The company has a market cap of $160.75 billion, a price-to-earnings ratio of 42.15, a P/E/G ratio of 4.22 and a beta of 0.83. Danaher has a 12 month low of $221.34 and a 12 month high of $281.70. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR) last announced its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.72% and a net margin of 16.33%. During the same quarter in the previous year, the company earned $2.09 earnings per share.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Coronation Fund Managers Ltd. lifted its position in shares of Danaher by 29.9% in the second quarter. Coronation Fund Managers Ltd. now owns 6,389 shares of the conglomerate’s stock worth $1,596,000 after purchasing an additional 1,470 shares in the last quarter. Quarry LP boosted its holdings in shares of Danaher by 250.6% during the second quarter. Quarry LP now owns 298 shares of the conglomerate’s stock worth $74,000 after acquiring an additional 213 shares during the period. Cetera Investment Advisers raised its stake in Danaher by 6.5% in the 2nd quarter. Cetera Investment Advisers now owns 130,209 shares of the conglomerate’s stock worth $32,533,000 after purchasing an additional 7,986 shares in the last quarter. Sanctuary Advisors LLC acquired a new stake in Danaher during the second quarter worth approximately $19,512,000. Finally, Healthcare of Ontario Pension Plan Trust Fund increased its position in shares of Danaher by 21.4% in the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 45,434 shares of the conglomerate’s stock worth $11,352,000 after purchasing an additional 8,006 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Transactions at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the sale, the senior vice president now owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 11.10% of the company’s stock.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were paid a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 0.49%. The ex-dividend date of this dividend was Friday, December 27th. Danaher’s payout ratio is 20.45%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.